Funding relief, but conditions temper optimism The Lancet HIV ++... ++

Funding relief, but conditions temper optimism The Lancet HIV https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00035-4/fulltext?dgcid=raven_jbs_etoc_email Mar 2026 Volume 13Number 3e143-e212 https://www.thelancet.com/journals/lanhiv/issue/vol13no3/PIIS2352-3018(26)X2002-1 Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial Jayne Ellis, MSca,b jayne.ellis1@lshtm.ac.uk ∙ Gila Hale, BSca ∙ Laura J Nsangi, MPHa ∙ Abduljewad Wele, MScd ∙ Enos Kigozi, MSce ∙ Jane Gakuru, MBChBa ∙ et al. https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00246-2/fulltext?dgcid=raven_jbs_etoc_feature_lanhiv Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial Felix G Mhlanga, MMEDa fmhlanga@uz-ctrc.org ∙ Daniel W Szydlo, MSe ∙ Ashley J Mayo, MPHb ∙ Katherine Bunge, MDc ∙ Lee Fairlie, FCPaedsd ∙ Clemensia Nakabiito, MMEDf ∙ et al. https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00307-8/abstract?dgcid=raven_jbs_etoc_feature_lanhiv